Dental health is frequently altered in patients with chronic kidney disease. We conducted a prospective study on dental health in CKD patients with a specific interest in the association between dental health issues and the accumulation of uremic toxins in the saliva. A total of 88 patients were included in the study, with chronic kidney disease stage 2 to 5 (without kidney replacement). We analysed the total concentrations of eight uremic toxins (trimethylamine N-oxide -TMAO-, Indoxyl Sulfate, P-cresyl-sulfate, Indole 3-acetic acid, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid -CMPF-, Kynurenine, Hippuric acid and Phenylacetylglutamine) and three precursors of uremic toxins (Tyrosine, Phenylalanine and Tryptophan) in the saliva using LC-MS/MS. We observed, for the first time, the association between various dental scores: DMFT, FST, CPITN, and OHIS, and saliva uremic toxins and precursors: TMAO, indoxyl sulfate, or hippuric acid. Further prospective interventional studies are required to confirm our results.
Cluster randomised trials (CRTs) are commonly used to evaluate health service interventions, quality improvement programmes or public health initiatives that are implemented at a regional or organisational level. Many CRTs include only a limited number of clusters for practical reasons. Small numbers of clusters are associated with known analytical and design challenges. Identifying the breadth and diversity of problems associated with small numbers of clusters and potential solutions will help researchers plan more effective evaluations. We systematically searched the literature including methodological papers, trial papers and commentaries where the words "small numbers of clusters" or similar expression were close to words like "problem" or "solution" for any type of CRT. We identified 53 references from the Ovid, MedLine and Embase databases. Most references focus either on parallel group CRTs or on stepped wedge CRTs (17 (32.1%) references each). Challenges related to Type I error rate inflation or other inferential issues are identified in 32 (60.4%) references, and the risk of covariate imbalance between trial arms in 30 (56.6%), making these the most commonly mentioned problems. A variety of methods to control Type I error rate inflation have been proposed, but with some concerns raised over their performance down to very small numbers of clusters. Other challenges identified relate to the design or conduct (e.g. generalisability of results or cluster attrition) for which no solution was proposed in the included references. Operational definitions of a "small" number of clusters vary considerably across the literature from 3 to 50 (median 20). Most published stepped wedge trials, in particular, are what most methodological references would call small (in terms of number of clusters). Work on mitigating the problems arising from small numbers of clusters has tended to focus on the analysis of CRTs rather than their design (e.g. sample size justification) or conduct. Further work is still needed to develop simple, practical guidance to help triallists understand what challenges they will face and when, and how to optimise the performance of methods for CRTs with limited numbers of clusters.
ObjectivesCluster randomised trials (CRTs) are commonly used to evaluate healthcare interventions and policies in “real-world” settings. Many CRTs include only a limited number of clusters for practical, logistical, or methodological reasons. Small numbers of clusters are associated with known analytical and design challenges, though there is little consensus on exactly what constitutes a “small” number in practice. Identifying problems and potential solutions will help researchers plan more effective evaluations.MethodsWe performed a scoping review of the literature to identify any problems and/or potential solutions related to small numbers of clusters for any type of CRT. We identified 53 references from the Ovid, MedLine and Embase databases.ResultsMost articles focus specifically either on parallel group CRTs or on stepped wedge CRTs (17 (32.1%) sources each). Challenges related to Type I error rate inflation or other inferential issues are identified in 32 (60.4%) sources, and the risk of covariate imbalance between trial arms in 30 (56.6%), making these the most commonly mentioned problems. A variety of methods to control Type I error rate inflation have been proposed, but with some concerns raised over their performance down to very small numbers of clusters. Operational definitions of a “small” number of clusters vary considerably across the literature from 3 to 50 (median 20). Most published stepped wedge trials, in particular, are what most methodological articles would call small (in terms of number of clusters).ConclusionsWork on mitigating the problems arising from small numbers of clusters has tended to focus on the analysis of CRTs rather than their design (e.g. sample size justification) or conduct. Further work is still needed to develop simple, practical guidance to help triallists understand what challenges they will face and when, and how to optimise the performance of methods for CRTs with limited numbers of clusters.